We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACGN
12101
DELISTED
Aceragen Inc
ACGN
$186K ﹤0.01%
9,113
-3,746
-29% -$75.4K
BW icon
12102
PUT
Babcock & Wilcox
BW
$1.53B
$185K ﹤0.01%
23,500
+2,000
+9% +$16.5K
CLIR icon
12103
CALL
ClearSign Technologies
CLIR
$31.7M
$185K ﹤0.01%
3,850
-1,820
-32% -$86.1K
KYN icon
12104
CALL
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
$185K ﹤0.01%
20,800
-3,100
-13% -$24.9K
VTSI icon
12105
VirTra
VTSI
$36.6M
$185K ﹤0.01%
+25,161
New +$148K
TTOO
12106
CALL
DELISTED
T2 Biosystems, Inc
TTOO
$185K ﹤0.01%
31
+1
+3% +$6.46K
PCPC.WS
12107
DELISTED
Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75
PCPC.WS
$185K ﹤0.01%
86,312
-110,449
-56% -$207K
LEAP
12108
CALL
DELISTED
Ribbit LEAP, Ltd.
LEAP
$185K ﹤0.01%
+17,300
New +$187K
AYTU icon
12109
CALL
AYTU BioPharma
AYTU
$25.5M
$184K ﹤0.01%
+1,840
New +$216K
ETON icon
12110
CALL
Eton Pharmaceutcials
ETON
$1.68B
$184K ﹤0.01%
+29,800
New +$221K
SDIV icon
12111
CALL
Global X SuperDividend ETF
SDIV
$1.21B
$184K ﹤0.01%
4,333
-3,367
-44% -$144K
TLSIW icon
12112
TriSalus Life Sciences Warrant
TLSIW
$18.1M
$184K ﹤0.01%
185,587
-338
-0.2% -$334
HNP
12113
PUT
DELISTED
Huaneng Power Intl, Inc.
HNP
$184K ﹤0.01%
+11,600
New +$170K
ENBL
12114
PUT
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$184K ﹤0.01%
20,200
-17,500
-46% -$143K
BSQR
12115
CALL
DELISTED
BSQUARE Corporation
BSQR
$184K ﹤0.01%
+38,600
New +$102K
ACRS icon
12116
PUT
Aclaris Therapeutics
ACRS
$851M
$183K ﹤0.01%
10,400
-21,600
-68% -$491K
CVEO icon
12117
PUT
Civeo
CVEO
$344M
$183K ﹤0.01%
+10,300
New +$172K
INOD icon
12118
Innodata
INOD
$2.09B
$183K ﹤0.01%
26,062
-12,471
-32% -$84.5K
MBIO icon
12119
CALL
Mustang Bio
MBIO
$4.5M
$183K ﹤0.01%
73
-56
-43% -$137K
TRUE
12120
CALL
DELISTED
TrueCar
TRUE
$183K ﹤0.01%
32,300
+16,100
+99% +$81.1K
ORKA
12121
Oruka Therapeutics
ORKA
$7.35B
$183K ﹤0.01%
4,349
+2,749
+172% +$115K
QTNT
12122
DELISTED
Quotient Limited Ordinary Shares
QTNT
$183K ﹤0.01%
1,259
+702
+126% +$112K
SPNV.U
12123
DELISTED
Supernova Partners Acquisition Company, Inc. Units, each consisting of one share of Class A common s
SPNV.U
$183K ﹤0.01%
17,523
+3,773
+27% +$39.5K
HDSN
12124
CALL
Hudson Technologies
HDSN
$239M
$182K ﹤0.01%
53,400
+24,800
+87% +$59.8K
SPDN icon
12125
PUT
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$198M
$182K ﹤0.01%
+11,500
New +$188K

Similar funds

Citadel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Citadel Advisors held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Citadel Advisors's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Citadel Advisors's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Citadel Advisors added most to AT&T in Q2 2021, an estimated $877M increase.
  • Citadel Advisors's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Citadel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Citadel Advisors's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Citadel Advisors opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Citadel Advisors's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.